Introduction
Cyclosporine (CyA), a secreted fungal polypeptide discovered in 1972, has profound immunosuppressant properties in vitro and in vivo 1 and has been used clinically to inhibit rejection of transplanted organs. More recently, because of its unique immunomodulating properties, CyA has been used in humans for the treatment of chronic asthma, membranous glomerulonephropathy, immune-mediated thrombocytopenia in children, atopic dermatitis, psoriasis, lichen planus, and many other inflammatory dermatoses. 2– 5
Cyclosporine is gaining wide use in veterinary medicine. In cats, CyA administration has successfully prolonged acceptance of renal allografts. 6 Cyclosporine has been used successfully for


